Integration of genome-wide of Stat3 binding and epigenetic modification mapping with transcriptome reveals novel Stat3 target genes in glioma cells.

[1]  Bozena Kaminska,et al.  Nencki Genomics Database—Ensembl funcgen enhanced with intersections, user data and genome-wide TFBS motifs , 2013, Database J. Biol. Databases Curation.

[2]  Jing Zhang,et al.  Unique genome-wide map of TCF4 and STAT3 targets using ChIP-seq reveals their association with new molecular subtypes of glioblastoma. , 2013, Neuro-oncology.

[3]  Bradley E. Bernstein,et al.  Genome-wide Chromatin State Transitions Associated with Developmental and Environmental Cues , 2013, Cell.

[4]  B. Kamińska,et al.  STAT signaling in glioma cells. , 2013, Advances in experimental medicine and biology.

[5]  L. Hennighausen,et al.  Comprehensive meta-analysis of Signal Transducers and Activators of Transcription (STAT) genomic binding patterns discerns cell-specific cis-regulatory modules , 2013, BMC Genomics.

[6]  J. Bussink,et al.  Regulation of TRIB3 mRNA and Protein in Breast Cancer , 2012, PloS one.

[7]  A. Holmgren,et al.  Thioredoxin system in cell death progression. , 2012, Antioxidants & redox signaling.

[8]  Shane J. Neph,et al.  An expansive human regulatory lexicon encoded in transcription factor footprints , 2012, Nature.

[9]  Nathan C. Sheffield,et al.  The accessible chromatin landscape of the human genome , 2012, Nature.

[10]  R. Ghirlando,et al.  Chromatin domains, insulators, and the regulation of gene expression. , 2012, Biochimica et biophysica acta.

[11]  Bozena Kaminska,et al.  Novel small molecular inhibitors disrupt the JAK/STAT3 and FAK signaling pathways and exhibit a potent antitumor activity in glioma cells , 2012, Cancer biology & therapy.

[12]  Shao-Cong Sun,et al.  Peli: a family of signal-responsive E3 ubiquitin ligases mediating TLR signaling and T-cell tolerance , 2012, Cellular and Molecular Immunology.

[13]  B. Kamińska,et al.  Signal transducer and activator of transcription 1 (Stat1) maintains basal mRNA expression of pro‐survival stat3‐target genes in glioma C6 cells , 2011, Journal of cellular biochemistry.

[14]  Qiang Yu,et al.  TXNIP (VDUP-1, TBP-2): a major redox regulator commonly suppressed in cancer by epigenetic mechanisms. , 2011, The international journal of biochemistry & cell biology.

[15]  J. Lachuer,et al.  Preferential binding of the methyl-CpG binding domain protein 2 at methylated transcriptional start site regions , 2011, Epigenetics.

[16]  L. Påhlman,et al.  Cancer associated epigenetic transitions identified by genome-wide histone methylation binding profiles in human colorectal cancer samples and paired normal mucosa , 2011, BMC Cancer.

[17]  E. Dejardin,et al.  Biology and signal transduction pathways of the Lymphotoxin-αβ/LTβR system. , 2011, Cytokine & growth factor reviews.

[18]  Ziyan Wang,et al.  TRB3 interacts with SMAD3 promoting tumor cell migration and invasion , 2011, Journal of Cell Science.

[19]  Vsevolod J. Makeev,et al.  A deeper look into transcription regulatory code by preferred pair distance templates for transcription factor binding sites , 2011, Bioinform..

[20]  J. Bussink,et al.  Tribbles homolog 3 denotes a poor prognosis in breast cancer and is involved in hypoxia response , 2011, Breast Cancer Research.

[21]  P. Hwu,et al.  Peli 1 negatively regulates T-cell activation and prevents autoimmunity , 2011 .

[22]  K. Burnstein,et al.  GADD45gamma: a new vitamin D-regulated gene that is antiproliferative in prostate cancer cells. , 2010, Endocrinology.

[23]  Vladimir Shelest,et al.  DistanceScan: a tool for promoter modeling , 2010, Bioinform..

[24]  Aaron R. Quinlan,et al.  Bioinformatics Applications Note Genome Analysis Bedtools: a Flexible Suite of Utilities for Comparing Genomic Features , 2022 .

[25]  Gautier Koscielny,et al.  Ensembl’s 10th year , 2009, Nucleic Acids Res..

[26]  Michal Dabrowski,et al.  Probe set filtering increases correlation between Affymetrix GeneChip and qRT-PCR expression measurements , 2010, BMC Bioinformatics.

[27]  Jong Kyoung Kim,et al.  Prediction and Experimental Validation of Novel STAT3 Target Genes in Human Cancer Cells , 2009, PloS one.

[28]  A. Bonni,et al.  STAT3 regulation of glioblastoma pathogenesis. , 2009, Current molecular medicine.

[29]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[30]  Raffaele Calogero,et al.  Genome-wide discovery of functional transcription factor binding sites by comparative genomics: The case of Stat3 , 2009, Proceedings of the National Academy of Sciences.

[31]  L. Påhlman,et al.  Histone H3 lysine 27 trimethylation in adult differentiated colon associated to cancer DNA hypermethylation , 2009, Epigenetics.

[32]  P. Moynagh.  The Pellino family: IRAK E3 ligases with emerging roles in innate immune signalling. , 2009, Trends in immunology.

[33]  F. Ali-Osman,et al.  Constitutively Activated STAT3 Frequently Coexpresses with Epidermal Growth Factor Receptor in High-Grade Gliomas and Targeting STAT3 Sensitizes Them to Iressa and Alkylators , 2008, Clinical Cancer Research.

[34]  Clifford A. Meyer,et al.  Model-based Analysis of ChIP-Seq (MACS) , 2008, Genome Biology.

[35]  P. Devarajan,et al.  Ankyrin facilitates intracellular trafficking of alpha1-Na+-K+-ATPase in polarized cells. , 2008, American journal of physiology. Cell physiology.

[36]  D. Louis,et al.  Deregulation of a STAT3–Interleukin 8 Signaling Pathway Promotes Human Glioblastoma Cell Proliferation and Invasiveness , 2008, The Journal of Neuroscience.

[37]  D. Gold,et al.  Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation , 2008, Nature Genetics.

[38]  Jan Komorowski,et al.  Whole-genome maps of USF1 and USF2 binding and histone H3 acetylation reveal new aspects of promoter structure and candidate genes for common human disorders. , 2008, Genome research.

[39]  David E Levy,et al.  Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway. , 2008, Genes & development.

[40]  S. Berger.  The complex language of chromatin regulation during transcription , 2007, Nature.

[41]  P. Kleihues,et al.  Genetic pathways to primary and secondary glioblastoma. , 2007, The American journal of pathology.

[42]  K. Hess,et al.  A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo , 2007, Oncogene.

[43]  Bing Li,et al.  The Role of Chromatin during Transcription , 2007, Cell.

[44]  T. Kouzarides.  Chromatin Modifications and Their Function , 2007, Cell.

[45]  Ali Shilatifard,et al.  Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression. , 2006, Annual review of biochemistry.

[46]  Qian Tao,et al.  The Stress-Responsive Gene GADD45G Is a Functional Tumor Suppressor, with Its Response to Environmental Stresses Frequently Disrupted Epigenetically in Multiple Tumors , 2005, Clinical Cancer Research.

[47]  R. Jove,et al.  Stat3 regulates genes common to both wound healing and cancer , 2005, Oncogene.

[48]  L. Ivashkiv,et al.  Signaling by STATs , 2004, Arthritis research & therapy.

[49]  Saeed Tavazoie,et al.  Mapping Global Histone Acetylation Patterns to Gene Expression , 2004, Cell.

[50]  R. Lahesmaa,et al.  Early Target Genes of IL-12 and STAT4 Signaling in Th Cells1 , 2004, The Journal of Immunology.

[51]  A. Aguzzi,et al.  IL-6 is required for glioma development in a mouse model , 2004, Oncogene.

[52]  Long Yu,et al.  GADD45γ, down-regulated in 65% Hepatocellular Carcinoma (HCC) from 23 Chinese patients, inhibits cell growth and induces cell cycle G2/M arrest for Hepatoma Hep-G2 cell lines , 2003, Molecular Biology Reports.

[53]  B. Cochran,et al.  Knockdown of STAT3 expression by RNAi induces apoptosis in astrocytoma cells , 2003, BMC Cancer.

[54]  L. Naeger,et al.  Distinct requirements for the naturally occurring splice forms Stat4α and Stat4β in IL‐12 responses , 2003 .

[55]  D. W. Kim,et al.  Gadd45gamma expression is reduced in anaplastic thyroid cancer and its reexpression results in apoptosis. , 2003, The Journal of clinical endocrinology and metabolism.

[56]  J. Gommerman,et al.  Lymphotoxin/LIGHT, lymphoid microenvironments and autoimmune disease , 2003, Nature Reviews Immunology.

[57]  Wan-Wan Lin,et al.  Inhibition of IFN-γ-Mediated Inducible Nitric Oxide Synthase Induction by the Peroxisome Proliferator-Activated Receptor γ Agonist, 15-Deoxy-Δ12,14-Prostaglandin J2, Involves Inhibition of the Upstream Janus Kinase/STAT1 Signaling Pathway1 , 2003, The Journal of Immunology.

[58]  Jingwen Liu,et al.  Delineating an oncostatin M-activated STAT3 signaling pathway that coordinates the expression of genes involved in cell cycle regulation and extracellular matrix deposition of MCF-7 cells , 2003, Oncogene.

[59]  L. Naeger,et al.  Distinct requirements for the naturally occurring splice forms Stat4alpha and Stat4beta in IL-12 responses. , 2003, The EMBO journal.

[60]  Wan-Wan Lin,et al.  Inhibition of IFN-gamma-mediated inducible nitric oxide synthase induction by the peroxisome proliferator-activated receptor gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, involves inhibition of the upstream Janus kinase/STAT1 signaling pathway. , 2003, Journal of immunology.

[61]  G. Barnett,et al.  Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells , 2002, Oncogene.

[62]  D. Frank,et al.  The role of STATs in apoptosis. , 2002, Current molecular medicine.

[63]  S. Carreira,et al.  The Usf‐1 transcription factor is a novel target for the stress‐responsive p38 kinase and mediates UV‐induced Tyrosinase expression , 2001, The EMBO journal.

[64]  T. Yeatman,et al.  Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[65]  P. Bucher,et al.  DNA Binding Specificity of Different STAT Proteins , 2001, The Journal of Biological Chemistry.

[66]  Teruo Hayashi,et al.  Regulating ankyrin dynamics: Roles of sigma-1 receptors. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[67]  B. Nelson,et al.  The IL-2 Receptor Promotes Lymphocyte Proliferation and Induction of the c-myc, bcl-2, and bcl-x Genes Through the trans-Activation Domain of Stat51 , 2000, The Journal of Immunology.

[68]  Mikhail Chernov,et al.  Regulation of c‐myc expression by IFN‐γ through Stat1‐dependent and ‐independent pathways , 2000 .

[69]  G R Stark,et al.  Regulation of c-myc expression by IFN-gamma through Stat1-dependent and -independent pathways. , 2000, The EMBO journal.

[70]  J. Turkson,et al.  Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. , 1999, Immunity.

[71]  A. J. Valente,et al.  A complex element regulates IFN-gamma-stimulated monocyte chemoattractant protein-1 gene transcription. , 1998, Journal of immunology.

[72]  Y. Fujio,et al.  Signals through gp130 upregulate bcl-x gene expression via STAT1-binding cis-element in cardiac myocytes. , 1997, The Journal of clinical investigation.

[73]  N. Shibagaki,et al.  Interferon γ-dependent Induction of Human Intercellular Adhesion Molecule-1 Gene Expression Involves Activation of a Distinct STAT Protein Complex* , 1997, The Journal of Biological Chemistry.

[74]  J. Darnell,et al.  A STAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain. , 1995, Genes & development.

[75]  K. Angelides,et al.  Ankyrin and spectrin associate with voltage-dependent sodium channels in brain , 1988, Nature.

[76]  W. Nelson,et al.  Ankyrin binding to (Na+ + K+)ATPase and implications for the organization of membrane domains in polarized cells , 1987, Nature.